Menopausal women increasingly receive ADHD diagnoses as midlife symptoms emerge

Reports show ADHD diagnoses among women aged 30 to 49 rose markedly between 2020 and 2022, and clinicians say perimenopause can reveal or worsen lifelong ADHD as estrogen levels change and affect focus.

Many midlife women report new or worsening trouble with attention and memory during perimenopause. Some describe everyday tasks becoming harder and feeling overwhelmed. Clinicians and researchers have noted an increase in ADHD diagnoses among women in their 30s and 40s in recent years. Experts link these changes to hormonal shifts that can unmask or amplify lifelong attention differences. Key points: - A 2023 Epic Research Study reported that ADHD diagnoses among women aged 30 to 49 nearly doubled from 2020 to 2022. - Clinicians say perimenopause often reveals or exacerbates long-standing ADHD rather than causing it, because declining estrogen can reduce support for dopamine-related executive function and focus. - Many women were not diagnosed as children because female ADHD symptoms often presented as anxiety, emotional dysregulation, or disorganization and were overlooked when ADHD was seen mainly as a boys' condition. - Some patients report improvement after hormone replacement therapy, ADHD evaluation, therapy, or medication, and the CDC reported substantial increases in stimulant use among midlife adults from 2020 to 2021, including notable rises for women aged 50 to 54. Summary: The reported rise in diagnoses has led clinicians and advocates to highlight screening and better menopause education in medical training. Many women described relief after diagnosis and treatment, while others spoke of grief about symptoms resurfacing. Undetermined at this time.